So, DS Sigma Holdings Berhad has an ROCE of 8.9%. On its own that's a low return on capital but it's in line with the industry's average returns of 8.9%. While the past is not representative of ...

So, DS Sigma Holdings Berhad has an ROCE of 8.9%. On its own that's a low return on capital but it's in line with the industry's average returns of 8.9%. While the past is not representative of the ...

What's next for the new-and-improved healthcare giant? The post Sigma shares race to another record high. What's next?

Our fair value estimate is JPY 5,600, implying a forward enterprise value/adjusted EBITDA (excluding nonoperating items) of 14.5 times our fiscal 2024 estimate, ending February 2025. Our weighted ...

The traditional full line pharmacy wholesale distribution business, retail and private label products. Also has national Presence in the hospital pharmacy distribution market, and through its ...

Franklin Resources Inc. purchased a new stake in Aurora Innovation, Inc. (NASDAQ:AUR – Free Report) during the third quarter, Holdings Channel reports. The firm purchased 12,354 shares of the ...

What does 2025 have in store for the domestic IPO and capital raisings ... liquidity. A line of sight to index inclusion soon ...

Equiti, a leading global fintech, announced that it has received in-principle approval from the Securities and Commodities ...

This gives Quadria a minority stake in Aragen, at a valuation of about $ 1.4 billion, primarily through fresh capital infusion, with a small portion from the sale of shares by existing investors ...

The IPO of Capital Infra Trust’s infrastructure investment ... The Issue is being made through the book-building process, wherein not more than 75 per cent of the offer would be available ...

NOT FOR DISTRIBUTION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES ...